Free Trial

Astera Labs (NASDAQ:ALAB) Stock Price Up 13.7% - Time to Buy?

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Shares surged 13.7% to $216.87, with trading volume 37% above average, following a recent steep sell-off.
  • Astera beat quarterly earnings and revenue expectations, reporting revenue of about $585 million, up 153.6% year over year, and forecast roughly $740 million in fourth-quarter revenue at the midpoint.
  • Analyst views are mixed: the consensus rating is Moderate Buy with a $320.85 price target, while concerns about valuation and AI-stock sentiment remain despite strong results.
  • Five stocks to consider instead of Astera Labs.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares rose 13.7% during trading on Monday. The stock traded as high as $220.08 and last traded at $216.87. Approximately 7,049,015 shares changed hands during trading, an increase of 37% from the average session volume of 5,161,966 shares. The stock had previously closed at $190.71.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Astera reported third-quarter revenue of about $585 million, ahead of expectations, and forecast fourth-quarter revenue of about $740 million at the midpoint. An analyst article also highlighted rising revenue per accelerator as customers adopt higher-value Scorpio switches, which could support continued growth and strong margins. Astera Labs Is Increasing Their Revenue Per Accelerator
  • Neutral Sentiment: After falling 26% over five sessions despite strong results, ALAB was described as testing resistance in an oversold bounce. This may indicate a recovery attempt, though it does not yet confirm that the prior decline has ended. ALAB Price Prediction
  • Negative Sentiment: Director Stefan Dyckerhoff disclosed sales of Astera Labs shares on November 5. The transactions were made under a pre-arranged Rule 10b5-1 plan, which makes them a less direct signal about the director’s outlook, but insider sales can still weigh on sentiment. SEC Form 4 filing
  • Negative Sentiment: The recent sell-off despite strong earnings suggests investors remain concerned about ALAB’s valuation and shifting sentiment toward AI stocks. Strong data-center growth reported by larger chipmakers may validate demand, but also underscores competition for AI infrastructure spending. Astera Labs Stock Drops 26% in a Week

Analysts Set New Price Targets

Several equities analysts have weighed in on ALAB shares. Roth Capital restated a "buy" rating and set a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. BMO Capital Markets began coverage on Astera Labs in a report on Thursday. They set an "outperform" rating and a $375.00 price objective on the stock. Susquehanna cut their price objective on Astera Labs from $310.00 to $258.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Weiss Ratings cut Astera Labs from a "buy (b-)" rating to a "hold (c)" rating in a research report on Friday, October 23rd. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $320.85.

Read Our Latest Research Report on Astera Labs

Astera Labs Trading Up 13.7%

The stock has a fifty day simple moving average of $300.46 and a 200-day simple moving average of $255.80. The stock has a market cap of $37.90 billion, a price-to-earnings ratio of 86.40 and a beta of 3.86.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million during the quarter, compared to analysts' expectations of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The firm's revenue was up 153.6% on a year-over-year basis. During the same quarter last year, the company earned $0.49 earnings per share. Sell-side analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares in the company, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 408,558 shares of company stock worth $126,050,884 in the last ninety days. Company insiders own 10.40% of the company's stock.

Institutional Trading of Astera Labs

Several large investors have recently added to or reduced their stakes in the company. Harbour Investments Inc. raised its position in Astera Labs by 15.9% in the 3rd quarter. Harbour Investments Inc. now owns 3,231 shares of the company's stock valued at $1,150,000 after buying an additional 444 shares during the last quarter. AlTi Global Inc. lifted its stake in Astera Labs by 1.1% in the third quarter. AlTi Global Inc. now owns 5,977 shares of the company's stock valued at $2,128,000 after purchasing an additional 67 shares during the last quarter. Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Astera Labs during the 3rd quarter worth $794,000. Danske Bank A S increased its stake in shares of Astera Labs by 9.4% in the third quarter. Danske Bank A S now owns 75,605 shares of the company's stock worth $26,913,000 after purchasing an additional 6,505 shares in the last quarter. Finally, Drive Wealth Management LLC raised its holdings in Astera Labs by 68.8% during the 3rd quarter. Drive Wealth Management LLC now owns 1,065 shares of the company's stock valued at $379,000 after acquiring an additional 434 shares during the period. 60.47% of the stock is owned by institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines